The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: The Caerphilly Study

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 551-557

  Patterson, Christopher C ^a   Smith, Anne E ^a   Yarnell, John W G ^a   Rumley, Ann ^b   Ben Shlomo, Yoav ^c   Lowe, Gordon D O ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cardiovascular risk; Inflammatory markers; Prospective study

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PLASMA VISCOSITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM;

ALPHA-MACROGLOBULINS; BIOLOGICAL MARKERS; BLOOD VISCOSITY; C-REACTIVE PROTEIN; CORONARY DISEASE; FIBRINOGEN; GREAT BRITAIN; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STROKE;

EID: 77950020199     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.030     Document Type: Article

References (25)

1. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008, 54:24-38.
2. Yarnell J.W., Baker I.A., Sweetnam P.M., et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991, 3:836-844.
3. Yarnell J.W.G., Patterson C.C., Sweetnam P.M., Lowe G.D.O. Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies. Eur Heart J 2004, 25:1049-1056.
4. Lowe G.D.O., Sweetnam P.M., Yarnell J.W.G., et al. C-reactive protein, fibrin D-dimer, and risk of ischaemic heart disease: the Caerphilly and Speedwell studies. Arterioscler Thromb Vasc Biol 2004, 24:1-7.
5. Elwood P.C., Yarnell J.W.G., Sweetnam P.M., O'Brien J.R. Plasma viscosity and fibrinogen in The Caerphilly and Speedwell Studies. Clin Hemorheol 1992, 12:545-548.
6. Danesh J., Lewington S., Thompson S.G., et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005, 294:1799-1809.
7. Danesh J., Collins R., Peto R., Lowe G.D.O. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2001, 21:515-520.
8. Wheeler J.G., Mussolino M.E., Gillum R., Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1794 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004, 25:1287-1292.
9. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leucocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998, 279:1477-1482.
10. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New Engl J Med 2004, 350:1387-1397.
11. Kerr R., Stirling D., Ludlam C.A. Interleukin 6 and haemostasis. Br J Haematol 2001, 115:3-12.
12. Danesh J., Kaptoge S., Mann A.G., et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008, 5(4):e78. 10.1371/journal.pmed.0050078.
13. Smith A., Patterson C.C., Yarnell J.W.G., et al. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly study. Circulation 2005, 112:3080-3087.
14. Yu S., Lowe G.D.O., Yarnell J.W.G., Sweetnam P.M. Resonance-thrombography of the haemostatic process in relation to risk of incident coronary heart disease: 9 years follow-up in the Caerphilly Prospective Heart Disease Study. Br J Haematol 2004, 126:385-391.
15. Deaton C.D., Maxwell K.W., Smith R.S., Creveling R.L. Use of laser nephelometry in the measurement of serum proteins. Clin Chem 1976, 22:1465-1471.
16. Schafer J.L. Multiple imputation: a primer. Stat Methods Med Res 1999, 8:3.
17. Royston P. Multiple imputation of missing values: further update of ice, with an emphasis on interval censoring. Stata J 2007, 7:445-464.
18. Woodward M., Rumley A., Tunstall-Pedoe H., Lowe G.D.O. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 1999, 104:246-257.
19. Bermudez E.A., Rifai N., Buring J., Manson J.E., Ridker P.M. Interrelationships among circulating interleukin 6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002, 22:1668-1673.
20. Wannamethee S.G., Whincup P.H., Rumley A., Lowe G.D.O. Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost 2007, 5:1637-1643.
21. Welsh P., Woodward M., Rumley A., Lowe G. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 2008, 141:852-861.
22. Tzoulaki I., Murray G.D., Price J.F. Hemostatic factors, inflammatory markers and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am J Epidemiol 2006, 163:334-341.
23. Saremi A., Anderson R.J., Luo P., et al. Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT). Atherosclerosis 2009, 203:610-614.
24. Baker I.A., Pickering J., Elwood P.C., Bayer A., Ebrahim S. Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: evidence from the Caerphilly and Speedwell cohort. Thromb Haemost 2002, 87:421-425.
25. Ridker P.M. Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). Thromb Haemost 2009, 7(1):332-339.